Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Oncology: Basic, Translational & Therapy

  • You have access
    Bevacizumab treatment reduces targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies
    Sandra Heskamp, Hanneke van Laarhoven, Janneke Molkenboer-Kuenen, Wim Oyen, Winette van der Graaf and Otto Boerman
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 12;
  • You have access
    Positron emission mammography (PEM): Beyond F-18-FDG
    Mathew Thakur, Kaijun Zhang, Adam Berger, Barbara Cavanaugh, Sung Kim, Andrea Frangos, Colleen Dascenzo, Eric Wickstrom and Charles Intenzo
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 11;
  • You have access
    Segmentation-based analysis of spatial concordance between images of intratumoral uptake of 18F-fluorothymidine (18F-FLT) and distribution of cell proliferation markers
    Marian Axente, Jun He, Christopher Bass, Jerry Hirsch, Gobalakrishnan Sundaresan, Jeffrey Williamson, Jamal Zweit and Andrei Pugachev
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 5;
  • You have access
    Efficient construction of PET/fluorescence probe based on sarcophagine cage: An opportunity to integrate diagnosis with treatment
    Shuanglong Liu, Dan Li, Chiun-Wei Huang, Li-Peng Yap, Ryan Park, Hong Shan, Zibo Li and Peter Conti
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 3;

Pages

  • Previous
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire